Subcutaneous immunoglobulin replacement therapy for primary antibody deficiency: advancements into the 21st century
- 1 August 2008
- journal article
- review article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 101 (2) , 114-121
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Safety and efficacy of subcutaneous human immunoglobulin in children with primary immunodeficiencyActa Paediatrica, 2007
- Pharmacoeconomic evaluation of immunoglobulin treatment in patients with antibody deficiencies from the perspective of the German statutory health insuranceThe European Journal of Health Economics, 2005
- Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at homeJournal of Allergy and Clinical Immunology, 2004
- Immunoglobulin replacement treatment by rapid subcutaneous infusionArchives of Disease in Childhood, 1998
- Slow subcutaneous human intravenous immunoglobulin in the treatment of antibody immunodeficiency: Use of an old method with a new product☆☆☆★Journal of Allergy and Clinical Immunology, 1998
- Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costsThe Lancet, 1995
- Adverse Effects of Intravenous ImmunoglobulinDrug Safety, 1993
- The life situations of patients with primary antibody deficiency untreated or treated with subcutaneous gammaglobulin infusionsClinical and Experimental Immunology, 1993
- Prophylactic effect of self-administered pump-driven subcutaneous IgG infusion in patients with antibody deficiency: a triple-blind cross-over study comparing P-IgG levels of 3 g l−1versus 6 g l−1Journal of Internal Medicine, 1991
- SUBCUTANEOUS IMMUNOGLOBULIN HOME TREATMENT IN HYPOGAMMAGLOBULINAEMIAThe Lancet, 1986